Package 67046-1602-3

Brand: abacavir

Generic: abacavir
NDC Package

Package Facts

Identity

Package NDC 67046-1602-3
Digits Only 6704616023
Product NDC 67046-1602
Product ID 67046-1602_48c0d443-a111-0039-e063-6394a90a9076
Description

30 TABLET in 1 BLISTER PACK (67046-1602-3)

Marketing

Marketing Status
Marketed Since 2021-04-01
Brand abacavir
Generic abacavir
Sample Package No

Linked Drug Pages (1)

Abacavir ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "48c0d443-a111-0039-e063-6394a90a9076", "openfda": {"unii": ["J220T4J9Q2"], "rxcui": ["242679"], "spl_set_id": ["42ca758a-1694-c614-e063-6294a90a8c7e"], "manufacturer_name": ["Coupler LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BLISTER PACK (67046-1602-3)", "package_ndc": "67046-1602-3", "marketing_start_date": "20210401"}], "brand_name": "Abacavir", "product_id": "67046-1602_48c0d443-a111-0039-e063-6394a90a9076", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 1A1 Inhibitors [MoA]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "67046-1602", "generic_name": "Abacavir", "labeler_name": "Coupler LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Abacavir", "active_ingredients": [{"name": "ABACAVIR SULFATE", "strength": "300 mg/1"}], "application_number": "ANDA091560", "marketing_category": "ANDA", "marketing_start_date": "20210401", "listing_expiration_date": "20271231"}